HopeStage
Back to all studies
CompletedNCT02583243

Project BEST: Connecting People With Opioid Use to Buprenorphine Treatment

About this titleRead the official source — NCT02583243
Observational studyAges 18–65United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2005
Recruitment status
Completed
Enrollment listed in the registry
209
Sponsor
Yale University
Sponsor type
University
Study type
Observational
Intervention type
Behavioural, Drug
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02583243
Official title
Show the full official title

Project BEST: Buprenorphine Entry Into Substance Abuse Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including Buprenorphine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies